 send to a friend by email
2025-08-07
According to the financial statements of Jerusalem Pharmaceuticals Company JPH for the first half of 2025, Net profit after tax of the period reached 3,956,009 USD Compared with Net profit after tax 1,262,976 USD for 2024, a net increase in profit of 213.23%.Total assets of the company reached 102,093,101 USD compared with total assets of 89,154,171 USD at the end of year 2024, a net increase of 14.51%.Total liabilities of the company reached 23,499,439 USD compared with total liabilities of 17,547,164 USD at the end of year 2024, a net increase of 33.92%. Net ownership equity of the company reached 78,593,662 USD (Including Non-Controlling Interests of 1,060,754 USD) compared with total owner equity of 71,607,007 USD (Including Non-Controlling Interests of 1,010,817 USD) at the end of year 2024, a net increase of 9.76%.
|
-trade
